References
- Lebrec D, Nouel O, Corbie M, Benhamou J P. Propranolol-A medical treatment for portal hypertension?. Lancet 1980; 2: 180–182
- Lebrec D, Hillon P, Munoz C, Goldfarb G, Nouel O, Benhamou J P. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982; 2: 523–527
- Cales P, Braillon A, Jiron I J, Lebrec D. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. J Hepatol 1984; 1: 37–46
- Garcia-Tsao G, Grace N, Groszmann R, et al. Short-term effects of propranolol on portal venous pressure. Hepatology 1986; 1: 101–106
- Bosch J, Masti R, Kravetz D, et al. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 1984; 4: 1200–1205
- Bendtsen F, Henriksen J H, SØrensen T I A, Christensen N J. Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity of disease and splanchnic haemo-dynamics. J Hepatol 1990; 10: 198–204
- Vorobioff J, Picabea E, Villavicencio R, et al. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology 1987; 4: 648–653
- Groszmann R J, Bosch J, Grace N D, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99: 1401–1407
- Pomier-Layrargues G, Villeneuve J P, Willems B, Huet P M, Marleau D. Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo. Gastroenterology 1987; 93: 1218–1224
- The PROVA Study Group. Randomized multi-center trial of sclerotherapy and/or propranolol for prophylaxis of first hemorrhage from oesophageal varices in cirrhosis. Medicine Group (UK), Abingdon 1990; 1192, In: Abstracts of World Congress of Gastroenterology (Sydney, 1990)
- Henriksen J H. Variability of hydrostatic hepatic vein and ascites fluid pressure in patients with liver cirrhosis. Scand J Clin Invest 1980; 40: 430–435
- Henriksen J H, Bendtsen F, SØrensen T I A, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989; 97: 1506–1513
- Henriksen J H, Winkler K. Hepatic blood flow determination. A comparison of 99mTc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol 1987; 4: 66–70
- Bosch J, Groszmann R. Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood through gas-troesophageal collaterals in cirrhosis. Hepatology 1984; 4: 424–429
- Gluud C, Henriksen J H, Copenhagen Study Group for Liver Diseases. Liver haemodynamics and function in alcoholic cirrhosis. Relation to testosterone treatment and ethanol consumption. J Hepatol 1987; 4: 168–173
- Henriksen J H, Christensen N J, Ring-Larsen H. Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics. Clin Physiol 1981; 1: 293–304
- Bichet D G, Van Putten V T, Schrier E W. Potential role of increased sympathetic activity in impaired sodium and water retention in cirrhosis. N Engl J Med 1982; 307: 1152–1157
- Keller U, Gerber P P G, Buhler F R, Stauffacher W. Role of the splanchnic bed in extracting circulating adrenaline and noradrenaline in patients with cirrhosis of the liver. Clin Sci 1984; 67: 45–49
- Willet J R, Esler M, Jennings G, Dudley F J. Sympathetic tone modulates portal venous pressure in alcoholic cirrhosis. Lancet 1986; 2: 939–943
- Morlan R, Lee S, Hadengue A, Braillon L A, Lebrec D. Hemodynamic effects of a clonidine-induced decrease in sympathetic tone in cirrhosis. Hepatology 1987; 7: 149–154
- Bendtsen F, Henriksen J H, SØrensen T I A. Propranolol and haemodynamic response in cirrhosis. J Hepatol 1991, (in press)
- Bendtsen F, Henriksen J H, Becker U, SØrensen T I A. Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in cirrhosis. J Hepatol 1987; 5: 137–143
- Vinel J P, Caucanas J P, Cales P, Suduca J M, Voigt J J, Pascal J P. Effect of propranolol on metabolic activity of the liver in patients with cirrhosis. J Hepatol 1988; 7: 186–192
- Kroeger R, Groszmann R J. Effect of selective blockade of beta-2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model. Gastroenterology 1985; 88: 896–900
- Lebrec D, Poynard T, Bernau J, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355–358
- Pascal J P, Cales P, Multicenter Study Group. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987; 317: 856–861
- Ideo G, Bellati G, Fesce E, Grimoldi D. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology 1988; 8: 6–9